- Home
- CII vs BLFS Comparison
CII vs BLFS Comparison
Compare CII & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CII | BLFS |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.0M | 923.5M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CII | BLFS |
|---|---|---|
| Price | $24.74 | $24.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 70.8K | ★ 429.0K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ N/A | $1,235.25 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $19.95 | $17.86 |
| 52 Week High | $26.17 | $29.57 |
Technical Indicators
Market Signals| Indicator | CII | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 63.59 | 62.58 |
| Support Level | $23.04 | $23.74 |
| Resistance Level | $25.34 | $26.55 |
| Average True Range (ATR) | 0.35 | 1.19 |
| MACD | -0.08 | 0.27 |
| Stochastic Oscillator | 61.85 | 77.08 |
Price Performance
Historical ComparisonAbout CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.